David J. McConkey, PhD of Johns Hopkins Greensberg Bladder Cancer Institute gives his opinion on what physicians need to know about the progress being made in treating bladder cancer with checkpoint inhibitors at the 2017 Genitourinary Cancers Symposium (Annual Meeting GU) in Orlando, Florida.
Progress with Checkpoint Inhibitors in Treating Bladder Cancer
